University Of Science Technical And Technologies De Bamako — Malaria Vaccine Clinical Trial (Alassane Dicko)

Open Philanthropy recommended a grant of $630,123 over three years to the University Of Science Technical And Technologies De Bamako to participate in a phase III clinical trial of a malaria vaccine developed by the Jenner Institute at the University of Oxford. Dr. Alassane Dicko will serve as the University’s principal investigator. The trial, funded by the Serum Institute of India, will be conducted in collaboration with the Institut des Sciences et Techniques, Bobo-Dioulasso; the Institut de Recherche en Sciences de la Santé; the KEMRI Wellcome Trust Research Programme; and the Ifakara Health Institute.

This falls within our focus area of scientific research, specifically within our interest in advancing human health and wellbeing.

Institut des Sciences et Techniques, Bobo-Dioulasso — Malaria Vaccine Clinical Trial (Jean Bosco Ouedraogo)

Open Philanthropy recommended a grant of $631,162 over three years to the Institut des Sciences et Techniques, Bobo-Dioulasso to participate in a phase III clinical trial of a malaria vaccine developed by the Jenner Institute at the University of Oxford. Dr. Jean Bosco Ouedraogo will serve as the Institut’s principal investigator. The trial, funded by the Serum Institute of India, will be conducted in collaboration with the University Of Science Technical And Technologies De Bamako, the Institut de Recherche en Sciences de la Santé, the KEMRI Wellcome Trust Research Programme, and the Ifakara Health Institute.

This falls within our focus area of scientific research, specifically within our interest in advancing human health and wellbeing.

Institut de Recherche en Sciences de la Santé — Malaria Vaccine Clinical Trial (Halidou Tinto)

Open Philanthropy recommended a grant of $630,123 over three years to the Institut de Recherche en Sciences de la Santé to participate in a phase III clinical trial of a malaria vaccine developed by the Jenner Institute at the University of Oxford. Dr. Halidou Tinto will serve as the Institut’s principal investigator. The trial, funded by the Serum Institute of India, will be conducted in collaboration with the University Of Science Technical And Technologies De Bamako; the Institut des Sciences et Techniques, Bobo-Dioulasso; the KEMRI Wellcome Trust Research Programme; and the Ifakara Health Institute.

This falls within our focus area of scientific research, specifically within our interest in advancing human health and wellbeing.

KEMRI-Wellcome Trust Research Programme — Malaria Vaccine Clinical Trial (Philip Bejon)

Open Philanthropy recommended a grant of $472,016 over three years to The KEMRI-Wellcome Trust Research Programme to participate in a phase III clinical trial of a malaria vaccine developed by the Jenner Institute at the University of Oxford.  Dr. Philip Bejon will serve as the Programme’s principal investigator. The trial, funded by the Serum Institute of India, will be conducted in collaboration with the University Of Science Technical And Technologies De Bamako; the Institut des Sciences et Techniques, Bobo-Dioulasso; the Institut de Recherche en Sciences de la Santé; and the Ifakara Health Institute.

This falls within our focus area of scientific research, specifically within our interest in advancing human health and wellbeing.

UC San Diego — Cost-Benefit Analysis for Malaria Suppression

Image courtesy of the University of California, San Diego.

Open Philanthropy recommended a grant of $190,000 to the University of California, San Diego to support Professor Omar Akbari and two collaborators at UC Berkeley and the London School of Hygiene & Tropical Medicine. They will model the costs and benefits of implementing Professor Akbari’s pgSIT method to suppress transmission of malaria in peri-urban areas of Africa.

This falls within our focus area of scientific research, specifically within our interest in advancing human health and wellbeing.

International Vaccine Institute — Cholera Vaccine Clinical Trial

Open Philanthropy recommended a grant of $2,500,000 over three years to the International Vaccine Institute (IVI) to support a phase I clinical trial of a conjugate vaccine for cholera. IVI will run the clinical trial in partnership with EuBiologics. The trial will be conducted in South Korea with a focus on safety and tolerability in humans, and will test different doses and formulations for the vaccine.

This falls within our focus area of scientific research, and specifically within our interest in advancing human health and wellbeing.

Life Sciences Research Foundation — Young Investigators (2022)

Open Philanthropy recommended a grant of $751,000 to the Life Sciences Research Foundation to support early-career investigators. The funds will support four postdoctoral fellows for three years apiece. The fellows have proposed research projects investigating immunology, virology, and gastroenterology.

Fellows

Alexa Weingarden (Info)

Arthur Kim (Info)

Ian Boys (Info)

Tiago Bruno Rezende de Castro (Info)

 

This follows our April 2019 support and falls within our focus area of scientific research, specifically within our interest in advancing transformative basic science.

Duke University — COVID-19 Antiviral Studies (Timothy Haystead)

Open Philanthropy recommended a grant of $14,355 to Duke University to enable Professor Timothy Haystead to collaborate with researchers at UC Davis and the Weill Cornell Medical College of Cornell University to study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus.

This follows our May 2020 support for earlier phases of the study at Duke University and falls within our work on scientific research, specifically our interest in science supporting biosecurity and pandemic preparedness.

iGEM — Support for Team ABSI_Kenya’s Project

Open Philanthropy recommended two grants totaling $8,500 to the International Genetically Engineered Machine (iGEM) Foundation to cover the registration fees for Africa Biosynthetic Solutions and Innovations, Kenya (Team ABSI_Kenya), to participate in the iGEM Synthetic Biology competition, which we have previously funded. Team ABSI_Kenya is a team of young Kenyan scientists from various disciplines who are working to develop a biosensor and filter to detect and remove microbial and chemical contaminants in drinking water in low-resource settings.

This falls within our work on scientific research, specifically within our interest in advancing human health and wellbeing.

Ifakara Health Institute — Malaria Vaccine Clinical Trial (Ally Olotu)

Open Philanthropy recommended a grant of $68,184 over three years to the Ifakara Health Institute to participate in a phase III clinical trial of a malaria vaccine developed by the Jenner Institute at the University of Oxford. Dr. Ally Olotu will serve as the Ifakara Health Institute’s principal investigator. The trial, funded by the Serum Institute of India, will be conducted in collaboration with the University Of Science Technical And Technologies De Bamako; the Institut des Sciences et Techniques, Bobo-Dioulasso; the Institut de Recherche en Sciences de la Santé; and the KEMRI Wellcome Trust Research Programme.

This falls within our work on scientific research, specifically within our interest in advancing human health and wellbeing.